Latest Gross Margins News

Cyclopharm has reported record third-quarter US Technegas revenue of A$1.62 million, with 76% generated by recurring consumable orders. Its installed base and hospital pipeline expanded sharply after new clinical guidelines preferred Technegas when available, while quarterly cash burn fell to A$0.9 million.

8common remained EBITDA and operating-cashflow positive in the September quarter, even as revenue fell 7.8% year on year. Its $1.9 million Australian Taxation Office contract is yet to contribute revenue, with implementation expected to begin in January.

SRJ Technologies has won a US$301,000 purchase order for its BoltEx flange integrity technology, marking its first significant deployment in the Middle East. The full contract value is scheduled to be paid before delivery to the end operator, giving the order unusually strong payment protection.

Saluda Medical delivered a strong operational start to FY27, with US implants up 55% and quarterly revenue rising 26% to US$23.1 million. But the medical device company ended September with US$73.6 million in cash, US$100 million of secured debt drawn and estimated funding for just 2.3 quarters at the quarter’s cash-use rate.

BetMakers delivered a step-change in Q1 FY27 profitability, with constant-currency revenue rising 16.3% and adjusted EBITDA climbing 176% to $5.9 million. Positive operating cash flow and stronger margins add weight to the company’s technology-led growth story, although the figures remain unaudited.

Fluence has already exceeded its full-year 2025 EBITDA after nine months of 2026, but delayed customer decisions have cut order intake and pushed operating cash flow into the red. The ASX-listed water treatment group is betting on a stronger fourth quarter to convert its improving margins into cash and backlog.

Xamble Group’s revenue held near its record quarter in Q3 CY2026, while gross margin improved and net operating cash outflow fell to A$0.05 million. The turnaround remains incomplete: underlying business EBITDA was still negative and the quarter benefited from A$0.15 million in grant income.

Vinyl Group delivered record Q1 FY27 revenue of A$6.33 million and entered the December quarter with record bookings, but ended September with only A$777,000 in cash and 0.45 quarters of reported funding. The company has increased chairman Ken Gaunt’s unsecured facility by A$2 million while it works to collect more than A$5 million in receivables.

AoFrio’s nine-month revenue fell 20% to NZ$50.3 million as motor sales plunged, while EBITDA dropped to NZ$0.8 million. The NZX-listed refrigeration technology company is relying on new US bottler orders, Food Retail expansion and its IoT platform to support a more profitable 2027.

Comvita has moved from NZ$62.4 million of net debt to NZ$0.5 million of net cash in a year, while FY27 first-quarter sales rose 4.6%. The sharper test now is whether its operating reset can convert a stronger balance sheet into durable shareholder returns, with no FY27 dividend expected and board control still contested.

Data#3 has upgraded its FY27 first-half profit projection after delivering record FY26 sales, earnings and dividends. The company expects strong early-year growth, although one-off transactions and a softer second-half growth rate will shape the full-year result.

Adheris Health delivered a stronger first quarter on revenue, margins and its CY27 sales pipeline, but ended September with US$3.5 million in cash after a US$3.1 million operating outflow. The company also disclosed the impending loss of a major pharmacy partner and a US$2.3 million-plus legal claim.